Division of Cardiology

Eva Lonn

MD (Hebrew University, Jerusalem), MSc (HRM, McMaster), FRCPC, FACC

Professor, Division of Cardiology, Department of Medicine

Associate Member, Dept of Clinical Epidemiology & Biostatistics

Director, Vascular Research Ultrasound Laboratory, Population Health Research Institute



Clinical Interests

Dr. Lonn has been the director of echocardiography for many years and continues to be an active member of the echocardiography group. Additional clinical interests include  cardiovascular prevention, coronary care unit and general cardiology.

Research Interests

Dr. Lonn's current research interests include clinical trials in the primary and secondary prevention of cardiovascular diseases, vascular imaging in atherosclerosis, the study of traditional and emerging cardiovascular risk factors, cardiovascular epidemiology and the use of echocardiographic methods for the assessment of left ventricular mass and left ventricular systolic and diastolic function. Dr. Lonn was the principal investigator of several large international multicentre cardiovascular prevention trials and trials in atherosclerosis using carotid intima media thickness. Currently she is Co-Principal investigator of the HOPE-3 trial and of several trials in atherosclerosis.

Selected Publications

  1. Morrison, KM, Dyal L, Conner W, Helden E, Newkirk L, Yusuf S, Lonn E. Cardiovascular risk factors and non-invasive assessment of subclinical atherosclerosis in youth. Atherosclerosis; 2009 Jul 23. [Epub ahead of print].
  2. Lonn E, Gerstein H, Sheridan P, Smith S, Diaz R, Mohan V, Bosch J, Yusuf S, Dagenais G for the DREAM  and STARR Investigators. Effect of ramipril and of rosiglitazone on carotid intima-media thickness in people with impaired glucose tolerance or impaired fasting glucose.  J Am Coll Cardiol 2009;53:2028-2035.
  3. Lonn E, Yusuf S. Arnold MJ, Sheridan P, Pogue J, Micks M, McQueen MJ, Probstfield J, Fodor G, Held C, Genest J Jr; Heart Outcomes Prevention Evaluation (HOPE) 2 Investigators Homocysteine lowering with folic acid & B vitamins in vascular disease. N Engl J Med 2006;354:1567-77.
  4. Lonn E, Bosch J, Arnold M, Arnold A, Ross C, Dagenais GR, Yusuf S, for The HOPE and HOPE-TOO Study Investigators.  Effects of long-term vitamin E supplementation on cardiovascular events and cancer. The HOPE study extension; JAMA, 2005;293:1338-167.
  5. Lonn E, Yusuf S, Dzavik V, Doris I, Yi Q, Smith S, Moore-Cox A, Bosch J, Riley WA, Teo KK, for the SECURE Investigators.  Effects of ramipril and of vitamin E on atherosclerosis: results of the prospective randomized Study to Evaluate Carotid Ultrasound changes in patients treated with Ramipril and vitamin E (SECURE). Circulation 2001;103:919-925.